GX1
GENXONE
NEWCONNECT
LISTED
Shareholders
as of September 20, 2026 · source: notifications under Art. 69 of the Offering Act · 3 entities above 5%
FREE FLOAT
The portion of capital not covered by notifications above 5% — its composition is not publicly known.
39.06%
—
LARGEST STAKE
40.31%
Diagnostyka Spółka Akcyjna
TOP 3 CONCENTRATION
Combined stake of the three largest shareholders above the 5% threshold.
60.94%
3 entities above 5%
LATEST CHANGE
June 23, 2026
ESPI (wykaz z WZ)
Ownership structure
stakes per latest notifications
SHAREHOLDERS ≥5% 60.94%
FREE FLOAT 39.06%
HOLDER
STAKE
SHARES
VOTES
NOTIFICATION
Diagnostyka Spółka Akcyjna
40.31%
1,332,138
40.31%
August 16, 2026
Michał Kaszuba
12.97%
428,470
12.97%
August 16, 2026
Carpathia Capital Alternatywna Spółka Inwestycyjna Spółka Akcyjna
7.66%
253,069
7.66%
August 16, 2026
Other
39.06%
—
39.06%
—
Diagnostyka Spółka Akcyjna
40.31%
1,332,138 shares · notification August 16, 2026
Michał Kaszuba
12.97%
428,470 shares · notification August 16, 2026
Carpathia Capital Alternatywna Spółka Inwestycyjna Spółka Akcyjna
7.66%
253,069 shares · notification August 16, 2026
Other
39.06%
— · composition undisclosed
Notification history
crossings above/below the 5% / 10% / 20% thresholdsJune 23, 2026
ESPI (wykaz z WZ) — baseline reading
Diagnostyka S.A.:
new in the registry, 40.31%
→
Capital and votes
Number of shares
—
ISIN
PLGENXN00013
Sector
Biotechnologia
Market
NEWCONNECT
Country
PL
Listing date
May 17, 2026
Where this data comes from
The structure is built from notifications shareholders file after crossing 5%, 10%, 15%, 20%, 25%, 33%, 50%, 75% and 90% of votes.
Below 5% there is no disclosure obligation, so the remaining capital is shown collectively as free float — its composition is not publicly known.
Stakes are not updated in real time. The date next to each entity is its last notification date, not today's date.